In accordance with the legislation, each package of Egis  products is labelled with a unique digital Data Matrix code, which contains information about the manufacturer, serial number and expiration date, batch number, as well as verify authenticity of the products. The transfer of this data to a unified system for monitoring the movement of medicines allows each citizen to track the path of goods throughout the supply chain: from the production lines to a pharmacy, a healthcare organization and a patient. The implementation of the system has a positive impact on almost all market players. Thus, manufacturers, distributors and pharmacy chains can optimize the stock and purchase management, healthcare organizations can improve the efficiency of drug supply to the end users, and patients can track the origin of the drug to be sure of its quality.

The integration with the Track&Trace system was implemented on time and without affecting to business processes.

“These results were largely achieved thanks to the local project team, which promptly informed colleagues from the Headquarters about current changes in legislation and was in constant contact with our partners from rfxcel. We are confident that its successful implementation will be able to increase the distribution chain transparency, make a significant contribution to prevent production and traffic counterfeit medicines and to improve end-user trust in the quality of medicines,” - say in EGIS-RUS.